CLINICAL_TRIALS trial_result · 2012-07-16

Clinical Trial Update: ADX10059 as an add-on Therapy to Proton Pump Inhibitors (PPIs) in Patients With Gastroesophageal Reflux (GERD) [Phase 2]

Phase 2 trial evaluating ADX10059 as an add-on therapy to proton pump inhibitors for gastroesophageal reflux disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Addex Pharma S.A. | Conditions: Gastroesophageal Reflux | Phase 2 | Status: COMPLETED